Literature DB >> 28402764

Ensuring Access to Injectable Generic Drugs - The Case of Intravesical BCG for Bladder Cancer.

Benjamin J Davies1, Thomas J Hwang1, Aaron S Kesselheim1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28402764     DOI： 10.1056/NEJMp1615697

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  15 in total

1.  Impact of Oncology Drug Shortages on Chemotherapy Treatment.

Authors:  Abby Alpert; Mireille Jacobson
Journal:  Clin Pharmacol Ther       Date:  2019-04-08       Impact factor: 6.875

2.  Drug Industry Groups Oppose FDA "Quality Metrics" Plan: The Agency Wants to Use Manufacturing Data to Attack Drug Shortages.

Authors:  Stephen Barlas
Journal:  P T       Date:  2017-07

3.  Effect of Intravesical Instillation of Gemcitabine vs Saline Immediately Following Resection of Suspected Low-Grade Non-Muscle-Invasive Bladder Cancer on Tumor Recurrence: SWOG S0337 Randomized Clinical Trial.

Authors:  Edward M Messing; Catherine M Tangen; Seth P Lerner; Deepak M Sahasrabudhe; Theresa M Koppie; David P Wood; Philip C Mack; Robert S Svatek; Christopher P Evans; Khaled S Hafez; Daniel J Culkin; Timothy C Brand; Lawrence I Karsh; Jeffrey M Holzbeierlein; Shandra S Wilson; Guan Wu; Melissa Plets; Nicholas J Vogelzang; Ian M Thompson
Journal:  JAMA       Date:  2018-05-08       Impact factor: 56.272

4.  Generic Drugs in the United States: Policies to Address Pricing and Competition.

Authors:  Ravi Gupta; Nilay D Shah; Joseph S Ross
Journal:  Clin Pharmacol Ther       Date:  2019-01-10       Impact factor: 6.875

5.  Perioperative Intravesical Chemotherapy for Patients WithNon-Muscle-invasive Bladder Cancer: Understanding the Extent of and Sources of Variation in Guideline-recommended Use.

Authors:  Devon K Check; David S Aaronson; Matthew E Nielsen; Valerie S Lee; Isaac J Ergas; Janise M Roh; Lawrence H Kushi; Li Tang; Marilyn L Kwan
Journal:  Urology       Date:  2018-10-23       Impact factor: 2.649

Review 6.  Updates on the use of intravesical therapies for non-muscle invasive bladder cancer: how, when and what.

Authors:  Charles C Peyton; Juan Chipollini; Mounsif Azizi; Ashish M Kamat; Scott M Gilbert; Phillippe E Spiess
Journal:  World J Urol       Date:  2018-12-07       Impact factor: 3.661

7.  Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of urothelial cancer.

Authors:  Matthew D Galsky; Arjun V Balar; Peter C Black; Matthew T Campbell; Gail S Dykstra; Petros Grivas; Shilpa Gupta; Christoper J Hoimes; Lidia P Lopez; Joshua J Meeks; Elizabeth R Plimack; Jonathan E Rosenberg; Neal Shore; Gary D Steinberg; Ashish M Kamat
Journal:  J Immunother Cancer       Date:  2021-07       Impact factor: 13.751

8.  Clinicopathological Criteria Predictive of Recurrence Following Bacillus Calmette-Guérin Therapy Initiation in Non-Muscle-Invasive Bladder Cancer: Retrospective Cohort Study.

Authors:  Tracy Downs; Joseph Plasek; John Weissert; Kyle Richards; Kourosh Ravvaz
Journal:  JMIR Cancer       Date:  2021-06-22

9.  Synthesis, characterization, and biological activity of a triphenylphosphonium-containing imidazolium salt against select bladder cancer cell lines.

Authors:  Michael L Stromyer; Marie R Southerland; Uttam Satyal; Rahmat K Sikder; David J Weader; Jessi A Baughman; Wiley J Youngs; Philip H Abbosh
Journal:  Eur J Med Chem       Date:  2019-10-31       Impact factor: 7.088

Review 10.  Current Clinical Trials in Non-muscle-Invasive Bladder Cancer: Heightened Need in an Era of Chronic BCG Shortage.

Authors:  Vignesh T Packiam; Ryan P Werntz; Gary D Steinberg
Journal:  Curr Urol Rep       Date:  2019-11-28       Impact factor: 2.862
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.